Skip to main content
Livermore
Livermore
ZHEN

Tejara Capital Ltd

SEC CIK
0001879713
Latest filing
Aug 11, 2026

The latest 13F from Tejara Capital Ltd covers Q2 2026 (filed Aug 11, 2026): 66 long positions worth $243.3M. The top 10 holdings make up 46.0% of the portfolio, and the largest is Diversified Energy Co (DEC) at 10.4%. Livermore has 17 filings on Form 13F from this institution, going back to Q4 2022.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
25
Est. +$35.5M
Added
23
Est. +$40.9M
Reduced
16
Est. −$64.4M
Sold out
32
Est. −$80.5M

Top 5 holdings

Share of this quarter's portfolio value

  1. DECDiversified Energy Co
    10.4%$25.3MHistory
  2. FISFidelity National Information Services, Inc.
    4.7%$11.4MHistory
  3. ESTAEstablishment Labs Holdings Inc.
    4.6%$11.2MHistory
  4. ARAntero Resources Corp
    4.1%$9.99MHistory
  5. MRVIMaravai Lifesciences Holdings, Inc.
    4.1%$9.95MHistory

Share of portfolio

Top 5 holdings and the other 61 positions, by share of portfolio value

  1. DEC10.4%
  2. FIS4.7%
  3. ESTA4.6%
  4. AR4.1%
  5. MRVI4.1%
  6. Other 61 positions72.1%

Biggest buys

New and added positions, by estimated amount bought

  1. AESIAtlas Energy Solutions Inc.
    +$3.84MNewHistory
  2. EPAMEPAM Systems, Inc.
    +$3.78MAddedHistory
  3. FISFidelity National Information Services, Inc.
    +$3.69MAddedHistory
  4. BILLBILL Holdings, Inc.
    +$3.68MAddedHistory
  5. ARAntero Resources Corp
    +$3.64MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. CERTCertara, Inc.
    +1.99 pp1.5% → 3.5%History
  2. BILLBILL Holdings, Inc.
    +1.78 pp1.5% → 3.3%History
  3. FISFidelity National Information Services, Inc.
    +1.62 pp3.1% → 4.7%History
  4. ARAntero Resources Corp
    +1.58 pp2.5% → 4.1%History
  5. AESIAtlas Energy Solutions Inc.
    +1.58 pp0.0% → 1.6%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ESTAEstablishment Labs Holdings Inc.
    −$15.2MReducedHistory
  2. TFXTeleflex Inc
    −$14.5MSold outHistory
  3. MRVIMaravai Lifesciences Holdings, Inc.
    −$11.9MReducedHistory
  4. VTRSViatris Inc
    −$8.17MSold outHistory
  5. EVHEvolent Health, Inc.
    −$8.16MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TFXTeleflex Inc
    −4.78 pp4.8% → 0.0%History
  2. VTRSViatris Inc
    −2.69 pp2.7% → 0.0%History
  3. DNOWDNOW Inc.
    −1.45 pp5.3% → 3.9%History
  4. NOVNOV Inc.
    −1.37 pp1.4% → 0.0%History
  5. SLBSLB Limited
    −1.31 pp1.7% → 0.4%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$243.3M
−$60.1M (−19.8%) vs. prior quarter
Positions
66
−7 vs. prior quarter
Top 10 concentration
46.0%
Top 10 as share of value
Turnover
27.9%
Q2 2026, one quarter
Average holding period
4.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2022), so positions held before then are understated.

13F filings by quarter

15 quarters, going back to Q4 2022. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $303.4M (Q1 2026)

Q4 2022: $172.0MQ1 2023: $195.4MQ2 2023: $203.0MQ3 2023: $175.8MQ4 2023: $238.7MQ1 2024: $270.0MQ2 2024: $274.7MQ3 2024: $209.6MQ4 2024: $152.6MQ1 2025: $202.9MQ2 2025: $215.7MQ3 2025: $182.4MQ4 2025: $240.6MQ1 2026: $303.4MQ2 2026: $243.3M
Q4 2022Q2 2026
13F filings of Tejara Capital Ltd by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 11, 202666$243.3MDECFISESTAvs. Q1 2026SEC
Q1 2026May 12, 202673$303.4MDECESTADNOWvs. Q4 2025SEC
Q4 2025Feb 5, 202661$240.6MDECGLNGSDRLvs. Q3 2025SEC
Q3 2025Nov 4, 202546$182.4MDECCNRARQTvs. Q2 2025SEC
Q2 2025Aug 13, 202570$215.7MDECARQTHRTXvs. Q1 2025SEC
Q1 2025May 13, 202574$202.9MARQTHRTXROIVvs. Q4 2024SEC
Q4 2024Feb 10, 202554$152.6MARQTROIVBORRvs. Q3 2024SEC
Q3 2024Nov 13, 202455$209.6MROIVMREOARQTvs. Q2 2024SEC
Q2 2024Aug 14, 202467$274.7MROIVHRTXARQTvs. Q1 2024SEC
Q1 2024May 14, 202472$270.0MROIVSTNGHRTXvs. Q4 2023SEC
Q4 2023Feb 12, 202467$238.7MROIVGLNGTEVAvs. Q3 2023SEC
Q3 2023Nov 15, 2023Amended63$175.8MCGLNGBTUvs. Q2 2023SEC
Q2 2023Aug 11, 202369$203.0MCNRGLNGCCJvs. Q1 2023SEC
Q1 2023May 12, 202381$195.4MCNRGLNGCCJvs. Q4 2022SEC
Q4 2022Feb 15, 2023Amended93$172.0MCNRSTNGTDW–SEC

13D and 13G filings

Companies where Tejara Capital Ltd reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

1 company, largest stake first.

Companies where Tejara Capital Ltd owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
CRDLCardiol Therapeutics Inc.13G/A5.30%6.38M shares+0.10 ppfrom 5.20%Oct 23, 20252 filingsSep 23, 2026SEC

Latest filings

2 filings on file made by Tejara Capital Ltd or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Tejara Capital Ltd
CompanyFiled (ET)FormStakeChangeEvent dateFiling
CRDLCardiol Therapeutics Inc.Sep 23, 202612:16 PM ET13G/A5.30%6.38M shares+0.10 ppfrom 5.20%Sep 2, 2026SEC
CRDLCardiol Therapeutics Inc.Oct 23, 20256:43 PM ET13G5.20%5.13M sharesNewOct 17, 2025SEC